These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17504929)

  • 1. Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme.
    Holtkamp N; Ziegenhagen N; Malzer E; Hartmann C; Giese A; von Deimling A
    Neuro Oncol; 2007 Jul; 9(3):291-7. PubMed ID: 17504929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
    Nobusawa S; Stawski R; Kim YH; Nakazato Y; Ohgaki H
    Neuropathology; 2011 Dec; 31(6):583-8. PubMed ID: 21382095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene.
    Bralten LB; Kloosterhof NK; Gravendeel LA; Sacchetti A; Duijm EJ; Kros JM; van den Bent MJ; Hoogenraad CC; Sillevis Smitt PA; French PJ
    Genes Chromosomes Cancer; 2010 Jun; 49(6):509-17. PubMed ID: 20196086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma.
    Fischer U; Keller A; Leidinger P; Deutscher S; Heisel S; Urbschat S; Lenhof HP; Meese E
    Mol Cancer Res; 2008 Apr; 6(4):576-84. PubMed ID: 18403636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.
    Reifenberger G; Reifenberger J; Ichimura K; Meltzer PS; Collins VP
    Cancer Res; 1994 Aug; 54(16):4299-303. PubMed ID: 8044775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
    Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
    Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification in human gliomas.
    Collins VP
    Glia; 1995 Nov; 15(3):289-96. PubMed ID: 8586464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
    Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
    Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.
    Zietsch J; Ziegenhagen N; Heppner FL; Reuss D; von Deimling A; Holtkamp N
    PLoS One; 2010 Jul; 5(7):e11858. PubMed ID: 20686603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative amplification analysis of human glioma tissue and glioma derived fragment spheroids using reverse chromosome painting (RCP).
    Janka M; Fischer U; Tonn JC; Kerkau S; Roosen K; Meese E
    Anticancer Res; 1996; 16(5A):2601-6. PubMed ID: 8917357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
    Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
    PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas.
    Völker HU; Hagemann C; Coy J; Wittig R; Sommer S; Stojic J; Haubitz I; Vince GH; Kämmerer U; Monoranu CM
    Am J Clin Pathol; 2008 Jul; 130(1):50-7. PubMed ID: 18550470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas.
    Alonso ME; Bello MJ; Arjona D; Martinez-Glez V; de Campos JM; Isla A; Kusak E; Vaquero J; Gutierrez M; Sarasa JL; Rey JA
    Am J Clin Pathol; 2005 Jun; 123(6):900-6. PubMed ID: 15899783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.